Hear from real patients who say they've found the right treatment for them.

Through these stories of NovoSeven® RT patients, you'll learn about quick access to treatment and fast infusion, as well as the impact of MixPro® and compact packaging on their lifestyles.

Hear from real patients who say they've found the right treatment for them.

Through these stories of NovoSeven® RT patients, you'll learn about quick access to treatment and fast infusion, as well as the impact of MixPro® and compact packaging on their lifestyles.

Justin

  • 29 years old
  • Photographer and web designer
  • Lives with congenital hemophilia with inhibitors
  • Meet Justin

    In this video, Justin, who lives with congenital hemophilia with inhibitors, talks about his love of travel and how NovoSeven® RT fits in when he’s living life on the go. When he’s traveling internationally, the compact packaging of NovoSeven® RT allows him to take it along.

Justin

  • 29 years old
  • Photographer and web designer
  • Lives with congenital hemophilia with inhibitors
  • Meet Justin

    In this video, Justin, who lives with congenital hemophilia with inhibitors, talks about his love of travel and how NovoSeven® RT fits in when he’s living life on the go. When he’s traveling internationally, the compact packaging of NovoSeven® RT allows him to take it along.

Bob

  • 62 years old
  • Enjoys fishing and boating with his wife
  • Lives with congenital hemophilia with inhibitors
  • Meet Bob

    In this video, you’ll hear Bob discuss living with an inhibitor and how important he finds the quick infusion time of NovoSeven® RT. Find out how NovoSeven® RT fits into his life.

Bob

  • 62 years old
  • Enjoys fishing and boating with his wife
  • Lives with congenital hemophilia with inhibitors
  • Meet Bob

    In this video, you’ll hear Bob discuss living with an inhibitor and how important he finds the quick infusion time of NovoSeven® RT. Find out how NovoSeven® RT fits into his life.

Chase

  • 7 years old
  • Loves to go to the playground after school
  • Lives with congenital hemophilia with inhibitors
  • Meet Chase

    Chase was diagnosed with hemophilia as an infant. In this video, Chase and his grandmother discuss his favorite activities and how the quick infusion time and portability of NovoSeven® RT fit into their lives.

Chase

  • 7 years old
  • Loves to go to the playground after school
  • Lives with congenital hemophilia with inhibitors
  • Meet Chase

    Chase was diagnosed with hemophilia as an infant. In this video, Chase and his grandmother discuss his favorite activities and how the quick infusion time and portability of NovoSeven® RT fit into their lives.

Taylor

  • 20 years old
  • Student and traveler
  • Lives with congenital factor VII deficiency
  • Meet Taylor

    Taylor, who lives with congenital factor VII deficiency, loves to travel. Find out how the quick reconstitution of NovoSeven® RT fits in with the things she likes to do.

Taylor

  • 20 years old
  • Student and traveler
  • Lives with congenital factor VII deficiency
  • Meet Taylor

    Taylor, who lives with congenital factor VII deficiency, loves to travel. Find out how the quick reconstitution of NovoSeven® RT fits in with the things she likes to do.

Kali

  • 20 years old
  • Likes to travel and hike
  • Lives with Glanzmann's thrombasthenia with refractoriness to platelets
  • Meet Kali

    In this video, you'll hear from Kali about living with Glanzmann's thrombasthenia with refractoriness to platelets, and how she takes NovoSeven® RT along when she's on the go.

Kali

  • 20 years old
  • Likes to travel and hike
  • Lives with Glanzmann's thrombasthenia with refractoriness to platelets
  • Meet Kali

    In this video, you'll hear from Kali about living with Glanzmann's thrombasthenia with refractoriness to platelets, and how she takes NovoSeven® RT along when she's on the go.

Icon: 5-step purification process of NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

Recombinant manufacturing

minimizes risk of viral contamination.


Illustration: Removing syringe cap

New to treatment? It’s

easy to get started.


Syringe and vials of NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

Considering

NovoSeven® RT?


Selected Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and people with Glanzmann’s thrombasthenia who have a decreased or absent response to platelet transfusions
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia

Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

  • NovoSeven® RT should be used with caution if you have an increased risk for blood clots, such as with disseminated intravascular coagulation (DIC), clogged arteries, crush injury, septicemia (an infection in the blood), uncontrolled bleeding after giving birth, history of heart disease, liver disease, limited movement following surgery, in elderly people, in newborns, or if you are taking aPCCs/PCCs (activated or nonactivated prothrombin complex concentrates) with NovoSeven® RT.
  • Allergic reactions, including serious whole body allergic reactions, have been reported with NovoSeven® RT. Tell your healthcare provider if you are allergic to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. If you think you are having an allergic reaction, call your healthcare provider right away. Some signs of allergic reaction may include shortness of breath, rash, itching, redness of the skin, and fainting/dizziness.
  • People with Factor VII deficiency should be monitored by their healthcare provider for antibodies, which can cause NovoSeven® RT to stop working properly.

Side Effects

  • The most common and serious side effects are blood clots.
  • Tell your healthcare provider about any side effects that bother you or do not go away.

Use with Other Drugs

  • Blood clots may occur if NovoSeven® RT is given with Coagulation Factor XIII (13).

Please click here for Prescribing Information.

NovoSeven® RT is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.